Literature DB >> 26257178

Overlapping Requirements for Tet2 and Tet3 in Normal Development and Hematopoietic Stem Cell Emergence.

Cheng Li1, Yahui Lan2, Lianna Schwartz-Orbach3, Evgenia Korol4, Mamta Tahiliani4, Todd Evans2, Mary G Goll5.   

Abstract

The Tet family of methylcytosine dioxygenases (Tet1, Tet2, and Tet3) convert 5-methylcytosine to 5-hydroxymethylcytosine. To date, functional overlap among Tet family members has not been examined systematically in the context of embryonic development. To clarify the potential for overlap among Tet enzymes during development, we mutated the zebrafish orthologs of Tet1, Tet2, and Tet3 and examined single-, double-, and triple-mutant genotypes. Here, we identify Tet2 and Tet3 as the major 5-methylcytosine dioxygenases in the zebrafish embryo and uncover a combined requirement for Tet2 and Tet3 in hematopoietic stem cell (HSC) emergence. We demonstrate that Notch signaling in the hemogenic endothelium is regulated by Tet2/3 prior to HSC emergence and show that restoring expression of the downstream gata2b/scl/runx1 transcriptional network can rescue HSCs in tet2/3 double mutant larvae. Our results reveal essential, overlapping functions for tet genes during embryonic development and uncover a requirement for 5hmC in regulating HSC production.
Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26257178      PMCID: PMC4545447          DOI: 10.1016/j.celrep.2015.07.025

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  64 in total

1.  TET1 is a tumor suppressor of hematopoietic malignancy.

Authors:  Luisa Cimmino; Meelad M Dawlaty; Delphine Ndiaye-Lobry; Yoon Sing Yap; Sofia Bakogianni; Yiting Yu; Sanchari Bhattacharyya; Rita Shaknovich; Huimin Geng; Camille Lobry; Jasper Mullenders; Bryan King; Thomas Trimarchi; Beatriz Aranda-Orgilles; Cynthia Liu; Steven Shen; Amit K Verma; Rudolf Jaenisch; Iannis Aifantis
Journal:  Nat Immunol       Date:  2015-04-13       Impact factor: 25.606

Review 2.  Hematopoiesis.

Authors:  Madhumita Jagannathan-Bogdan; Leonard I Zon
Journal:  Development       Date:  2013-06       Impact factor: 6.868

3.  Combined deficiency of Tet1 and Tet2 causes epigenetic abnormalities but is compatible with postnatal development.

Authors:  Meelad M Dawlaty; Achim Breiling; Thuc Le; Günter Raddatz; M Inmaculada Barrasa; Albert W Cheng; Qing Gao; Benjamin E Powell; Zhe Li; Mingjiang Xu; Kym F Faull; Frank Lyko; Rudolf Jaenisch
Journal:  Dev Cell       Date:  2013-01-24       Impact factor: 12.270

4.  Ascorbic acid enhances Tet-mediated 5-methylcytosine oxidation and promotes DNA demethylation in mammals.

Authors:  Ruichuan Yin; Shi-Qing Mao; Bailin Zhao; Zechen Chong; Ying Yang; Chao Zhao; Dapeng Zhang; Hua Huang; Juan Gao; Zheng Li; Yan Jiao; Cuiping Li; Shengquan Liu; Danni Wu; Weikuan Gu; Yun-Gui Yang; Guo-Liang Xu; Hailin Wang
Journal:  J Am Chem Soc       Date:  2013-07-01       Impact factor: 15.419

5.  Modulation of TET2 expression and 5-methylcytosine oxidation by the CXXC domain protein IDAX.

Authors:  Myunggon Ko; Jungeun An; Hozefa S Bandukwala; Lukas Chavez; Tarmo Aijö; William A Pastor; Matthew F Segal; Huiming Li; Kian Peng Koh; Harri Lähdesmäki; Patrick G Hogan; L Aravind; Anjana Rao
Journal:  Nature       Date:  2013-04-07       Impact factor: 49.962

6.  Sperm, but not oocyte, DNA methylome is inherited by zebrafish early embryos.

Authors:  Lan Jiang; Jing Zhang; Jing-Jing Wang; Lu Wang; Li Zhang; Guoqiang Li; Xiaodan Yang; Xin Ma; Xin Sun; Jun Cai; Jun Zhang; Xingxu Huang; Miao Yu; Xuegeng Wang; Feng Liu; Chung-I Wu; Chuan He; Bo Zhang; Weimin Ci; Jiang Liu
Journal:  Cell       Date:  2013-05-09       Impact factor: 41.582

7.  In vivo genome editing using a high-efficiency TALEN system.

Authors:  Victoria M Bedell; Ying Wang; Jarryd M Campbell; Tanya L Poshusta; Colby G Starker; Randall G Krug; Wenfang Tan; Sumedha G Penheiter; Alvin C Ma; Anskar Y H Leung; Scott C Fahrenkrug; Daniel F Carlson; Daniel F Voytas; Karl J Clark; Jeffrey J Essner; Stephen C Ekker
Journal:  Nature       Date:  2012-09-23       Impact factor: 49.962

8.  TET1 plays an essential oncogenic role in MLL-rearranged leukemia.

Authors:  Hao Huang; Xi Jiang; Zejuan Li; Yuanyuan Li; Chun-Xiao Song; Chunjiang He; Miao Sun; Ping Chen; Sandeep Gurbuxani; Jiapeng Wang; Gia-Ming Hong; Abdel G Elkahloun; Stephen Arnovitz; Jinhua Wang; Keith Szulwach; Li Lin; Craig Street; Mark Wunderlich; Meelad Dawlaty; Mary Beth Neilly; Rudolf Jaenisch; Feng-Chun Yang; James C Mulloy; Peng Jin; Paul P Liu; Janet D Rowley; Mingjiang Xu; Chuan He; Jianjun Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-01       Impact factor: 12.779

9.  Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells.

Authors:  Kathryn Blaschke; Kevin T Ebata; Mohammad M Karimi; Jorge A Zepeda-Martínez; Preeti Goyal; Sahasransu Mahapatra; Angela Tam; Diana J Laird; Martin Hirst; Anjana Rao; Matthew C Lorincz; Miguel Ramalho-Santos
Journal:  Nature       Date:  2013-06-30       Impact factor: 49.962

10.  Reprogramming the maternal zebrafish genome after fertilization to match the paternal methylation pattern.

Authors:  Magdalena E Potok; David A Nix; Timothy J Parnell; Bradley R Cairns
Journal:  Cell       Date:  2013-05-09       Impact factor: 41.582

View more
  38 in total

1.  RUNX1 regulates site specificity of DNA demethylation by recruitment of DNA demethylation machineries in hematopoietic cells.

Authors:  Takahiro Suzuki; Yuri Shimizu; Erina Furuhata; Shiori Maeda; Mami Kishima; Hajime Nishimura; Saaya Enomoto; Yoshihide Hayashizaki; Harukazu Suzuki
Journal:  Blood Adv       Date:  2017-09-06

Review 2.  DNA methylation in hematopoietic development and disease.

Authors:  Aniket V Gore; Brant M Weinstein
Journal:  Exp Hematol       Date:  2016-05-10       Impact factor: 3.084

3.  Mapping autosomal recessive intellectual disability: combined microarray and exome sequencing identifies 26 novel candidate genes in 192 consanguineous families.

Authors:  R Harripaul; N Vasli; A Mikhailov; M A Rafiq; K Mittal; C Windpassinger; T I Sheikh; A Noor; H Mahmood; S Downey; M Johnson; K Vleuten; L Bell; M Ilyas; F S Khan; V Khan; M Moradi; M Ayaz; F Naeem; A Heidari; I Ahmed; S Ghadami; Z Agha; S Zeinali; R Qamar; H Mozhdehipanah; P John; A Mir; M Ansar; L French; M Ayub; J B Vincent
Journal:  Mol Psychiatry       Date:  2017-04-11       Impact factor: 15.992

Review 4.  Mechanisms that regulate the activities of TET proteins.

Authors:  Kanak Joshi; Shanhui Liu; Peter Breslin S J; Jiwang Zhang
Journal:  Cell Mol Life Sci       Date:  2022-06-15       Impact factor: 9.207

Review 5.  Understanding the regulation of vertebrate hematopoiesis and blood disorders - big lessons from a small fish.

Authors:  Anne L Robertson; Serine Avagyan; John M Gansner; Leonard I Zon
Journal:  FEBS Lett       Date:  2016-09-25       Impact factor: 4.124

6.  TET is targeted for proteasomal degradation by the PHD-pVHL pathway to reduce DNA hydroxymethylation.

Authors:  Sijia Fan; Jing Wang; Guangqing Yu; Fangjing Rong; Dawei Zhang; Chenxi Xu; Juan Du; Zhi Li; Gang Ouyang; Wuhan Xiao
Journal:  J Biol Chem       Date:  2020-09-22       Impact factor: 5.157

7.  Epigenetic and Epitranscriptomic Factors Make a Mark on Hematopoietic Stem Cell Development.

Authors:  Dionna M Kasper; Stefania Nicoli
Journal:  Curr Stem Cell Rep       Date:  2018-02-03

8.  Active DNA demethylation at enhancers during the vertebrate phylotypic period.

Authors:  Ozren Bogdanović; Arne H Smits; Elisa de la Calle Mustienes; Juan J Tena; Ethan Ford; Ruth Williams; Upeka Senanayake; Matthew D Schultz; Saartje Hontelez; Ila van Kruijsbergen; Teresa Rayon; Felix Gnerlich; Thomas Carell; Gert Jan C Veenstra; Miguel Manzanares; Tatjana Sauka-Spengler; Joseph R Ecker; Michiel Vermeulen; José Luis Gómez-Skarmeta; Ryan Lister
Journal:  Nat Genet       Date:  2016-02-29       Impact factor: 38.330

Review 9.  TET-dioxygenase deficiency in oncogenesis and its targeting for tumor-selective therapeutics.

Authors:  Yihong Guan; Metis Hasipek; Anand D Tiwari; Jaroslaw P Maciejewski; Babal K Jha
Journal:  Semin Hematol       Date:  2020-12-28       Impact factor: 3.851

10.  A Therapeutic Strategy for Preferential Targeting of TET2 Mutant and TET-dioxygenase Deficient Cells in Myeloid Neoplasms.

Authors:  Yihong Guan; Anand D Tiwari; James G Phillips; Metis Hasipek; Dale R Grabowski; Simona Pagliuca; Priyanka Gopal; Cassandra M Kerr; Vera Adema; Tomas Radivoyevitch; Yvonne Parker; Daniel J Lindner; Manja Meggendorfer; Mohamed Abazeed; Mikkeal A Sekeres; Omar Y Mian; Torsten Haferlach; Jaroslaw P Maciejewski; Babal K Jha
Journal:  Blood Cancer Discov       Date:  2020-12-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.